相关实验视频

Updated: Jul 2, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

总en bloc脊椎切除术和免疫化疗用于与骨内淋巴瘤碰撞的软骨肉瘤

Luis Palacios-Diaz¹, Antonio J Aguilar Martínez^1,2, Francisco J Pérez Rodríguez³

¹Department of Orthopaedic Surgery and Traumatology, La Paz University Hospital, Madrid 28046, Spain.

Journal of surgical case reports

|February 19, 2024

概括

这项研究报告了第一例与扩散型大B细胞淋巴瘤发生碰撞的冠状腺癌病例. 患者需要手术切除和免疫化学疗法才能完全反应.

科学领域:

在瘤学瘤学.
病理学病理学病理学
手术瘤学手术瘤学

背景情况:

软骨肉瘤是软骨的恶性瘤.
扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤.
碰撞瘤,即同一部位发生两种不同的恶性瘤,是罕见的.

研究的目的:

报告第一个记录下来的1级胆固醇肉瘤与骨内外扩散大B细胞淋巴瘤相碰撞的病例.
讨论这种罕见的碰撞瘤的诊断和治疗含义.

主要方法:

一名59岁的女性患者被诊断为T7级I型冠状骨肉瘤,接受了全面的块状脊椎切除术.
对手术样本的组织病理学分析揭示了软骨肉瘤和DLBCL的共存.
进行了系统性分期,以排除传播疾病.

主要成果:

组织病理学证实了1级仅限于T7的冠状肉瘤,意外地与扩散大B细胞淋巴瘤相关.
该患者接受了四个周期的RCHOP (利图西马布,环胺,多克索鲁比辛,温克里斯和普雷德尼松) 免疫化学疗法.
手术和治疗后两年,患者实现了完全的代谢反应.

结论:

这一案例突出显示了第一个与淋巴瘤碰撞的冠状腺癌的实例.
虽然1级软骨肉瘤通常只需要手术切除,但同时出现的淋巴瘤需要全身免疫化疗.
完整的手术切除与全身治疗相结合,导致了有利的结果.

关键词:

这是一个RCHOP的RCHOP.这种疾病是chondrosarcoma.淋巴瘤淋巴瘤是什么脊椎切除术是一种脊椎切除术.

更多相关视频

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.